InsiderClue
Insiders · Profile

SASSINE ANDY

Chief Financial Officer at Arcturus Therapeutics · Director at MetaVia · Director at ACORN ENERGY. Filing since 18 Oct 2013. CIK 0001515322

ARCT Arcturus Therapeutics Holdings Inc. Chief Financial Officer · 6 trades MTVA MetaVia Inc. Director · 1 trade ACFN ACORN ENERGY, INC. Director · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ARCT Arcturus Therapeutics Holdings Inc.
15 Aug 2025
Chief Financial Officer
Sold at will
1,238
$20.50K
0.6%
ARCT Arcturus Therapeutics Holdings Inc.
12 Jun 2024
Chief Financial Officer
Sold at will
50,000
$1.60M
18.5%
ARCT Arcturus Therapeutics Holdings Inc.
10 Jun 2020
Chief Financial Officer
Bought
5,000
$148.70K
1.9%
ARCT Arcturus Therapeutics Holdings Inc.
5 Dec 2019
Chief Financial Officer
Bought
5,649
$54.96K
2.2%
ARCT Arcturus Therapeutics Holdings Inc.
3 Dec 2019
Chief Financial Officer
Bought
10,000
$100.00K
4.0%
ARCT Arcturus Therapeutics Holdings Inc.
23 Aug 2019
Chief Financial Officer
Bought
10,000
$109.00K
4.2%
MTVA MetaVia Inc.
10 Mar 2017
Director
Bought
21,119
$200.00K
18.3%
ACFN ACORN ENERGY, INC.
5 Jun 2014
Director
Bought
20,607
$34.60K
3.7%
ACFN ACORN ENERGY, INC.
4 Jun 2014
Director
Bought
212,077
$367.57K
61.8%
ACFN ACORN ENERGY, INC.
2 Dec 2013
Director
Bought
12,724
$45.43K
3.9%
ACFN ACORN ENERGY, INC.
27 Nov 2013
Director
Bought
22,158
$82.62K
7.2%
ACFN ACORN ENERGY, INC.
18 Oct 2013
Director
Bought
6,988
$22.71K
2.3%
12 decisions on file.